EZH2 can also collaborate with DNA methyltransferases (DNMTs) to reinforce gene silencing through DNA methylation and Polycomb group targets are more likely to have cancer-specific promoter DNA hypermethylation compared to non-targets [25]. Here, EZH2 is linked to cancer.